DTaP-IPV vaccine

DTaP-IPV vaccine is a combination vaccine whose full generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (IPV).[1] It is also known as DTaP/IPV, dTaP/IPV, DTPa-IPV, or DPT-IPV. It protects against the infectious diseases diphtheria, tetanus, pertussis, and poliomyelitis.

DTaP-IPV vaccine
DPT-IPV vaccine in Japan
Combination of
DTaP vaccineVaccine
Inactivated poliovirus vaccineVaccine
Clinical data
Trade namesKinrix, Quadracel, Boostrix-IPV, Infanrix-IPV, others
AHFS/Drugs.comKinrix Quadracel
Pregnancy
category
  • US: C (Risk not ruled out)
    Routes of
    administration    		Intramuscular injection
    ATC code

    Branded formulations marketed in the USA are Kinrix from GlaxoSmithKline[2] and Quadracel from Sanofi Pasteur.[3]

    References
    1. "Diphtheria, Tetanus, Pertussis (Acellular, Component) And Poliomyelitis (Inactivated) Vaccine (Adsorbed)". Drugs.com. Retrieved 15 July 2018.
    2. "Kinrix". US Food and Drug Administration. Retrieved 15 July 2018.
    3. "Quadracel". US Food and Drug Administration. Retrieved 15 July 2018.


    This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.